Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-10-29 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2024-08-12 | New | $1,302,084 | $1,302,084 | Equity Only | 06b | SEC link |
| 2024-08-12 | New | $450,000 | $450,000 | Equity Only | 06b | SEC link |
| 2024-03-20 | New | $2,624,000 | $2,624,000 | Equity Only | 06b | SEC link |
| 2017-07-26 | New | $4,047,993 | $4,047,993 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Robert Anderson | Director |
| Stuart Diamond | Director |
| Michael Dougherty | Executive |
| James Edwards | Executive |
| Barry Frankel | Director |
| Steven Girgenti | Director, Executive |
| Myron Holubiak | Director |
| Roby Joyce | Director |
| Peter S. Knight | Director |
| Jamie Platt | Director |
| Vivienne Rebel | Executive |
| Xavier Reveles | Executive |
| Gary Rubin | Director |
| Maria Zannes | Director, Executive |
| Timothy P. Zannes | Executive |